Stock listing
PHRX Stock Price, News, Filings & Events — Pharmadrug, Inc.
Selected listing: PHRX · CSE · CAD · CA
This page tracks Pharmadrug, Inc.'s PHRX:CSE listing on CSE in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PHRX:CSE. PHRX:CSE is the stock-level entry point for investors researching Pharmadrug, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pharmadrug, Inc. is a public company traded under the ticker PHRX on the Canadian market. The company has a market capitalization of approximately CAD 955,204. Pharmadrug focuses on developing and providing innovative solutions in the pharmaceutical sector.
- Ticker
- PHRX:CSE
- Asset type
- Stock
- Market cap
- $484,984
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- CSE
- Currency
- CAD
Pharmadrug, Inc. PHRX:CSE stock context
This page tracks Pharmadrug, Inc.'s PHRX:CSE listing on CSE in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PHRX:CSE. PHRX:CSE is the stock-level entry point for investors researching Pharmadrug, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pharmadrug, Inc. is a public company traded under the ticker PHRX on the Canadian market. The company has a market capitalization of approximately CAD 955,204. Pharmadrug focuses on developing and providing innovative solutions in the pharmaceutical sector.
Latest news from Pharmadrug, Inc.
PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring
January 5, 2026
PharmaDrug Announces Debt Restructuring
October 31, 2025
PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc
October 30, 2025
PharmaDrug Inc.: Correction to News Release Dated July 30, 2025
July 30, 2025
PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc.
July 30, 2025
Research Pharmadrug, Inc.
Pharmadrug, Inc. investor report
Review AI stock analysis and investor report context for PHRX:CSE.
Pharmadrug, Inc. company profile
View the public company page for Pharmadrug, Inc. on 6ix.
Pharmadrug, Inc. news
Read company news and market updates connected to Pharmadrug, Inc..
Pharmadrug, Inc. investor events
Find investor webinars, events, and replay context for Pharmadrug, Inc..
Alternate listings
G11:GETTEX
DE · EUR
Alternate listing for Pharmadrug, Inc.; the primary context on this page is PHRX:CSE.
LMLLF:OTC
US · USD
Alternate listing for Pharmadrug, Inc.; the primary context on this page is PHRX:CSE.
A3EURE:LSX
DE · EUR
Alternate listing for Pharmadrug, Inc.; the primary context on this page is PHRX:CSE.
PHRX:NEO
CA · CAD
Alternate listing for Pharmadrug, Inc.; the primary context on this page is PHRX:CSE.
A3EURE:LS
DE · EUR
Alternate listing for Pharmadrug, Inc.; the primary context on this page is PHRX:CSE.
G11:MUN
DE · EUR
Alternate listing for Pharmadrug, Inc.; the primary context on this page is PHRX:CSE.
G11:FWB
DE · EUR
Alternate listing for Pharmadrug, Inc.; the primary context on this page is PHRX:CSE.